NasdaqGS - Delayed Quote USD
Pliant Therapeutics, Inc. (PLRX)
1.3800
-0.0900
(-6.12%)
At close: May 13 at 4:00:01 PM EDT
1.4100
+0.03
+(2.17%)
After hours: May 13 at 5:33:53 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 11 |
| Avg. Estimate | -0.66 | -0.48 | -2.47 | -2.42 |
| Low Estimate | -1.09 | -0.57 | -2.89 | -6.64 |
| High Estimate | -0.48 | -0.36 | -2.08 | -0.71 |
| Year Ago EPS | -0.92 | -0.95 | -3.47 | -2.47 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | -- | -- | 1.67M | 1.25M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 20M | 15M |
| Year Ago Sales | -- | -- | -- | 1.67M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -25.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.98 | -0.96 | -0.75 |
| EPS Actual | -0.92 | -0.95 | -0.82 | -0.92 |
| Difference | -0.07 | 0.03 | 0.14 | -0.17 |
| Surprise % | -8.69% | 3.02% | 14.15% | -23.18% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.66 | -0.48 | -2.47 | -2.42 |
| 7 Days Ago | -0.62 | -0.6 | -2.29 | -2.66 |
| 30 Days Ago | -0.62 | -0.6 | -2.29 | -2.66 |
| 60 Days Ago | -0.63 | -0.6 | -2.47 | -2.68 |
| 90 Days Ago | -0.91 | -0.93 | -3.81 | -3.74 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PLRX | 28.32% | 49.29% | 28.78% | 2.27% |
| S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/4/2025 |
| Maintains | Citigroup: Neutral to Neutral | 3/4/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 3/4/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/4/2025 |
| Downgrade | Needham: Buy to Hold | 3/4/2025 |
Related Tickers
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2100
-6.20%
RAPT RAPT Therapeutics, Inc.
0.7479
-14.90%
NKTX Nkarta, Inc.
1.9400
-3.96%
CGEM Cullinan Therapeutics, Inc.
7.62
-3.67%
VOR Vor Biopharma Inc.
0.1600
-7.25%
ACRV Acrivon Therapeutics, Inc.
1.1300
-5.83%
STOK Stoke Therapeutics, Inc.
8.93
-7.56%
KYTX Kyverna Therapeutics, Inc.
2.3200
+4.98%
GBIO Generation Bio Co.
0.3927
+0.59%